TMO — Thermo Fisher Scientific Inc. stock price, charts and financials

QT65Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (NYSE: TMO) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
605.69
+2.67+0.44%
TMOQT65Thermo Fisher Scientific Inc.·NYSE
605.69+0.44%
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E32.58EPS (ttm)18.59Insider Own0.15%Shs Outstand371.62MPerf Week0.86%
Market Cap225.09BForward P/E22.11EPS next Y27.40Insider Trans-16.18%Shs Float370.65MPerf Month1.00%
Enterprise Value263.57BPEG2.95EPS next Q6.40Inst Own87.56%Short Float1.28%Perf Quarter22.59%
Income6.98BP/S4.86EPS this Y35.08%Inst Trans0.00%Short Ratio2.11Perf Half Y21.12%
Sales46.34BP/B4.27EPS next Y9.11%ROA6.17%Short Interest4.74MPerf YTD4.53%
Book/sh141.77P/C55.39EPS next 5Y11.06%ROE13.35%52W High646.97 -6.38%Perf Year24.21%
Cash/sh10.94P/FCF31.17EPS past 3/5Y0.19% 2.11%ROIC7.44%52W Low435.28 39.15%Perf 3Y8.70%
Dividend Est.1.88 (0.31%)EV/EBITDA24.10Sales past 3/5Y-0.27% 6.70%Gross Margin40.37%Volatility2.24% 2.39%Perf 5Y9.14%
Dividend TTM1.80 (0.30%)EV/Sales5.69EPS Y/Y TTM12.46%Oper. Margin17.69%ATR (14)15.85Perf 10Y294.56%
Dividend Ex-DateSep 15, 2026Quick Ratio1.18Sales Y/Y TTM8.06%Profit Margin15.06%RSI (14)52.86Recom2.16
Dividend Gr. 3/5Y12.75% 14.34%Current Ratio1.55EPS Q/Q12.50%SMA20-1.05%Beta0.88Target Price623.36
Payout9.49%Debt/Eq0.74Sales Q/Q10.49%SMA505.43%Rel Volume0.95Prev Close603.02
Employees125,000LT Debt/Eq0.67EarningsOct 28SMA20012.92%Avg Volume2.02MPrice605.69
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.5.43% 2.46%Net Debt/EBITDA3.52Volume1,915,749Change0.44%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-08-26ReiteratedUBSNeutral$615$730
Sep-03-26InitiatedCLSAOutperform$748
Aug-05-26ReiteratedStifel NicolausBuy$600$650
Jul-27-26ReiteratedPiper SandlerNeutral$510$600
Jul-24-26ReiteratedRBC CapitalSector Perform$490$580
Jul-23-26ReiteratedJefferiesHold$585$630
Jul-06-26ReiteratedEvercore ISI GroupOutperform$650$570
Jun-26-26ResumedBernsteinMarket Perform$520
Jun-11-26InitiatedPiper SandlerNeutral$510
Jun-03-26DowngradeHSBCBuyHold$670$540
Latest News· Times ET
Sep-09-26
Sep-08-26
Sep-07-26
Sep-04-26
Sep-03-26
Sep-02-26
Sep-01-26
Aug-29-26
Aug-28-26
Aug-27-26
Company

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Ownership
Total institutional ownership87.56%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue46,33644,55642,879
Cost of Goods Sold Incl. D&A27,62927,77825,151
Gross Profit18,70716,77817,728
Selling, General and Administrative Excl. Other8,0497,2728,676
Research and Development1,4041,3971,390
Other Operating Expense
1,06200
Operating Income8,1958,1097,662
Interest Expense1,4671,4191,654
Unusual Expense
Non-Operating Income (Expense)881577987
Net Income Before Taxes7,6097,2676,995
Income Taxes597547657
Consolidated Net Income6,9786,7376,335
Net Income From Continuing Operations7,0126,7206,338
Net Income6,9786,7376,335
EPS (Recurring)18.6217.7716.58
EPS (Basic, Before Extraordinaries)18.6217.7716.58
EPS (Diluted)18.5917.7416.53
EBITDA10,93511,46611,800
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio32.5832.6631.47
Price To Sales Ratio4.854.894.63
Gross Margin40.3737.6641.34
Operating Margin17.6918.2017.87
Net Margin15.0615.1214.77
Shares Outstanding371376382
Market Capitalization224,711217,873198,728
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$674.63$598.41$522.20$445.98$369.76 Close Price0.00M14.18M28.35M42.53M56.70MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Pettiti GianlucaPresident & COOAug 31 '26Sale614.383,7332,293,48123,216Sep 01
Pettiti GianlucaPresident & COOAug 31 '26Option Exercise309.633,7331,155,84926,949Sep 01
CASPER MARC NChairman & CEOAug 24 '26Sale627.05275172,438123,925Aug 26
CASPER MARC NChairman & CEOAug 24 '26Option Exercise309.6327585,148124,200Aug 26
CASPER MARC NChairman & CEOAug 21 '26Sale626.9210,0006,269,152123,925Aug 24
CASPER MARC NChairman & CEOAug 21 '26Option Exercise309.6310,0003,096,300133,925Aug 24
CASPER MARC NChairman & CEOAug 20 '26Sale629.2710,0006,292,669123,925Aug 24
CASPER MARC NChairman & CEOAug 20 '26Option Exercise309.6310,0003,096,30010,275Aug 24
Britt Lisa P.Sr. VP and Chief HR OfficerAug 19 '26Option Exercise418.3211,4404,785,58126,224Aug 20
Britt Lisa P.Sr. VP and Chief HR OfficerAug 19 '26Sale613.1211,4407,014,09314,784Aug 20
Shafer Michael DExecutive Vice PresidentAug 11 '26Option Exercise370.5825,5009,449,83235,294Aug 13
Shafer Michael DExecutive Vice PresidentAug 11 '26Sale600.0014,3008,580,00020,994Aug 13
Holmes Joseph R.VP & Chief Accounting OfficerAug 07 '26Option Exercise309.63420130,0453,386Aug 10
Holmes Joseph R.VP & Chief Accounting OfficerAug 07 '26Sale584.81420245,6202,966Aug 10
CASPER MARC NChairman & CEOAug 07 '26Option Exercise309.6327585,148124,200Aug 10
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.